A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Clinical trial NCT00051051 · COMPLETED

Trial details

NCT number: NCT00051051
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2002-12-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.